CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,586 | $8,368 | $4,327 | $7,989 |
| Dep. & Amort. | $4,597 | $4,366 | $4,224 | $4,486 |
| Deferred Tax | -$572 | -$676 | -$2,029 | -$402 |
| Stock-Based Comp. | $540 | $588 | $447 | $484 |
| Change in WC | $109 | $15 | $6,818 | $3,857 |
| Other Non-Cash | -$153 | $765 | $2,390 | $1,851 |
| Operating Cash Flow | $9,107 | $13,426 | $16,177 | $18,265 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,781 | -$3,031 | -$2,727 | -$2,520 |
| Net Acquisitions | -$95 | -$16,612 | -$1,388 | -$146 |
| Inv. Purchases | -$15,191 | -$9,043 | -$7,746 | -$9,963 |
| Inv. Sales/Matur. | $10,353 | $7,729 | $6,729 | $7,246 |
| Other Inv. Act. | $101 | $68 | $85 | $122 |
| Investing Cash Flow | -$7,613 | -$20,889 | -$5,047 | -$5,261 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5,059 | $7,932 | -$4,211 | -$9,267 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$3,023 | -$2,012 | -$3,500 | $0 |
| Dividends Paid | -$3,373 | -$3,132 | -$2,907 | -$2,625 |
| Other Fin. Act. | $202 | -$105 | $102 | $536 |
| Financing Cash Flow | -$1,135 | $2,683 | -$10,516 | -$11,356 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $359 | -$4,780 | $614 | $1,648 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,525 | $13,305 | $12,691 | $11,043 |
| End Cash | $8,884 | $8,525 | $13,305 | $12,691 |
| Free Cash Flow | $6,326 | $10,395 | $13,450 | $15,745 |